Literature DB >> 27132465

Thermal dosimetry for bladder hyperthermia treatment. An overview.

Gerben Schooneveldt1, Akke Bakker1, Edmond Balidemaj1, Rajiv Chopra2, Johannes Crezee1, Elisabeth D Geijsen1, Josefin Hartmann3, Maarten C C M Hulshof1, H Petra Kok1, Margarethus M Paulides4, Alejandro Sousa-Escandon5, Paul R Stauffer6, Paolo F Maccarini7.   

Abstract

The urinary bladder is a fluid-filled organ. This makes, on the one hand, the internal surface of the bladder wall relatively easy to heat and ensures in most cases a relatively homogeneous temperature distribution; on the other hand the variable volume, organ motion, and moving fluid cause artefacts for most non-invasive thermometry methods, and require additional efforts in planning accurate thermal treatment of bladder cancer. We give an overview of the thermometry methods currently used and investigated for hyperthermia treatments of bladder cancer, and discuss their advantages and disadvantages within the context of the specific disease (muscle-invasive or non-muscle-invasive bladder cancer) and the heating technique used. The role of treatment simulation to determine the thermal dose delivered is also discussed. Generally speaking, invasive measurement methods are more accurate than non-invasive methods, but provide more limited spatial information; therefore, a combination of both is desirable, preferably supplemented by simulations. Current efforts at research and clinical centres continue to improve non-invasive thermometry methods and the reliability of treatment planning and control software. Due to the challenges in measuring temperature across the non-stationary bladder wall and surrounding tissues, more research is needed to increase our knowledge about the penetration depth and typical heating pattern of the various hyperthermia devices, in order to further improve treatments. The ability to better determine the delivered thermal dose will enable clinicians to investigate the optimal treatment parameters, and consequentially, to give better controlled, thus even more reliable and effective, thermal treatments.

Entities:  

Mesh:

Year:  2016        PMID: 27132465     DOI: 10.3109/02656736.2016.1156170

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

Review 1.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

2.  Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.

Authors:  Andrew S Mikhail; Ayele H Negussie; William F Pritchard; Dieter Haemmerich; David Woods; Ivane Bakhutashvili; Juan Esparza-Trujillo; Sam J Brancato; John Karanian; Piyush K Agarwal; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2017-05-10       Impact factor: 3.914

Review 3.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

4.  Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model.

Authors:  Lifei Zhu; Ari Partanen; Michael R Talcott; H Michael Gach; Suellen C Greco; Lauren E Henke; Jessika A Contreras; Imran Zoberi; Dennis E Hallahan; Hong Chen; Michael B Altman
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

5.  Hyperthermia Treatment Planning Including Convective Flow in Cerebrospinal Fluid for Brain Tumour Hyperthermia Treatment Using a Novel Dedicated Paediatric Brain Applicator.

Authors:  Gerben Schooneveldt; Hana Dobšíček Trefná; Mikael Persson; Theo M de Reijke; Klas Blomgren; H Petra Kok; Hans Crezee
Journal:  Cancers (Basel)       Date:  2019-08-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.